Catalyst Pharma elects seven directors at annual meeting; Philip Coelho retires from board

CATALYST PHARMACEUTICALS, INC.

Patrick J. McEnany, Richard J. Daly, Donald A. Denkhaus, Molly Harper, Charles B. O’Keeffe, Tamar Thompson, and David S. Tierney elected to board for 2024 term.
Philip H. Coelho, board member since 2002, did not stand for re-election; retirement not due to any disagreement.
Shareholders approved amendment to 2018 Stock Incentive Plan with 73.2M for, 2.7M against.
Advisory vote on named executive officer compensation passed with 72.6M for, 2.9M against.
Ratification of Grant Thornton as auditor for FY2023 approved with 87.6M for, 0.3M against.

item 5.02 item 5.07

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Philip H. Coelho

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Effective: 2023-08-22
Filed: August 25, 2023, 7:59 PM ET

Philip H. Coelho, an independent member of the Board, did not stand for re-election at the Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Philip H. Coelho retired as Director at CATALYST PHARMACEUTICALS, INC..

Action: retired
Role: Director

Exact text from the filing

Philip H. Coelho, an independent member of the Board, did not stand for re-election at the Annual Meeting.

View on SEC.gov

CATALYST PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-221544

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.